Margaret has been with GE Capital for the past 14 years in various roles leading venture capital, venture debt and fund-of-fund investments into companies in the healthcare sector. Currently, as Vice President of GE Capital’s Life Sciences practice, she is responsible for leading venture debt and alternative investments into life sciences companies. She has served an an active board member to numerous portfolio companies.
Earlier, Margaret was with Psilos Partners, a $500MM fund where she led investments into healthcare services/IT companies. Previously, Margaret was the first hired employee and Director, Business Development at Paladin Laboratories (PLB), a leading public specialty pharmaceutical company that was sold to Endo Health Solutions (ENDP) in 2014. Margaret began her career as an investment banker at Salomon Brothers in New York where she originated and executed over $3.7 billion in IPOs and high yield bond offerings.
Margaret is an Adjunct Professor at Golden Gate University’s MBA program where she teaches several courses, including Venture Capital & Start Up Financing. She also initiated and leads the MBA’s inaugural Business Ethics program. Margaret is passionate about changing the world for the better, serving as an advisor to several socially-conscious start-ups and new initiatives at non-profits such as Asian Community Mental Health Services, UC Berkeley, Stanford Medical School’s Department of Psychiatry, among others. Margaret received her MBA from Harvard Business School and a BA from Clark University.